One Pager as on October 31, 2022
Prudent portfolio of investments across companies and sectors. | |
Actively managed by professional fund managers for potential long term capital appreciation. | |
Opportunity to participate in successful businesses through equity market. | |
Data as on October 31, 2022
Sector | MMMBY | Nifty 500 Multicap 50:25:25 TRI Index |
Financial Services | 27.09% | 26.43% |
Capital Goods | 19.98% | 6.92% |
Information Technology | 6.83% | 8.94% |
Construction Materials | 6.12% | 2.15% |
Fast Moving Consumer Goods | 5.10% | 6.97% |
Data as on October 31, 2022
Security | % to Net Assets |
Infosys Limited | 4.55% |
ICICI Bank Limited | 4.50% |
State Bank of India | 4.18% |
Ambuja Cements Limited | 3.11% |
Bharat Forge Limited | 3.03% |
United Spirits Limited | 2.78% |
IndusInd Bank Limited | 2.72% |
HDFC Bank Limited | 2.68% |
Bajaj Finance Limited | 2.51% |
Canara Bank | 2.35% |
Top 10 Holdings | 32.41% |
Fresh Additions | Complete Exits |
Security | Security |
Page Industries Limited | Graphite India Limited |
PVR Limited |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on October 31, 2022
Turnover Ratio (Last 1 year) | 1.30 |
Standard Deviation | 22.50% |
Beta1 | 0.88 |
Sharpe Ratio# | 0.75 |
Jenson's Alpha2 | 0.1832 |
#Risk-free rate assumed to be 6.25% (MIBOR as on 31-10-22) - Source: www.mmda.org
1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month since inception till October 31, 2022 and annualized. 2. Calculated for the period since inception till October 31, 2022. | Data Source: ICRA Analytics, Bloomberg | Data as on October 31, 2022 | N.A.: Net Assets
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha is managing this fund since December 21, 2020. Ms. Fatema Pacha is managing this scheme since October 16, 2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha and Ms. Fatema Pacha manage
9 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on October 31, 2022.
This product is suitable for investors who are seeking*:
• Medium to Long term capital
appreciation.
• Investment predominantly in
equity and equity related securities
including derivatives.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.